These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15947437)

  • 1. Structural analysis of the O-antigen of Francisella tularensis subspecies tularensis strain OSU 10.
    Thirumalapura NR; Goad DW; Mort A; Morton RJ; Clarke J; Malayer J
    J Med Microbiol; 2005 Jul; 54(Pt 7):693-695. PubMed ID: 15947437
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
    Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis.
    Prior JL; Prior RG; Hitchen PG; Diaper H; Griffin KF; Morris HR; Dell A; Titball RW
    J Med Microbiol; 2003 Oct; 52(Pt 10):845-851. PubMed ID: 12972577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a wild-type strain of Francisella tularensis isolated from a cat.
    Inzana TJ; Glindemann GE; Snider G; Gardner S; Crofton L; Byrne B; Harper J
    J Vet Diagn Invest; 2004 Sep; 16(5):374-81. PubMed ID: 15460318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Characterization of the Capsule-Like Complex (CLC) Produced by
    Champion AE; Bandara AB; Mohapatra N; Fulton KM; Twine SM; Inzana TJ
    Front Cell Infect Microbiol; 2018; 8():182. PubMed ID: 29963499
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Immunity to
    Roberts LM; Powell DA; Frelinger JA
    Front Cell Infect Microbiol; 2018; 8():115. PubMed ID: 29682484
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.
    Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL
    Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of Francisella tularensis in lesions of cats with tularemia.
    DeBey BM; Andrews GA; Chard-Bergstrom C; Cox L
    J Vet Diagn Invest; 2002 Mar; 14(2):162-4. PubMed ID: 11939340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.
    Apicella MA; Post DM; Fowler AC; Jones BD; Rasmussen JA; Hunt JR; Imagawa S; Choudhury B; Inzana TJ; Maier TM; Frank DW; Zahrt TC; Chaloner K; Jennings MP; McLendon MK; Gibson BW
    PLoS One; 2010 Jul; 5(7):e11060. PubMed ID: 20625403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen.
    Conlan JW; Vinogradov E; Monteiro MA; Perry MB
    Microb Pathog; 2003 Jan; 34(1):39-45. PubMed ID: 12620383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
    Cherwonogrodzky JW; Knodel MH; Spence MR
    Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Francisella tularensis vaccines.
    Griffin KF; Oyston PC; Titball RW
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.
    Raynaud C; Meibom KL; Lety MA; Dubail I; Candela T; Frapy E; Charbit A
    Infect Immun; 2007 Jan; 75(1):536-41. PubMed ID: 17030571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.